We serve Chemical Name:6-ISOPROPOXY-5-METHYLNICOTINIC ACID CAS:1011558-18-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-ISOPROPOXY-5-METHYLNICOTINIC ACID
CAS.NO:1011558-18-1
Synonyms:5-methyl-6-propan-2-yloxypyridine-3-carboxylic acid;6-Isopropoxy-5-methylnicotinic acid;3-Pyridinecarboxylic acid, 5-methyl-6-(1-methylethoxy)-
Molecular Formula:C10H13NO3
Molecular Weight:195.215
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:312.3±37.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.528
PSA:59.42000
Exact Mass:195.089539
LogP:2.23
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-methyl-6-propan-2-yloxypyridine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Pyridinecarboxylic acid, 5-methyl-6-(1-methylethoxy)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Isopropoxy-5-methylnicotinic acid Use and application,3-Pyridinecarboxylic acid, 5-methyl-6-(1-methylethoxy)- technical grade,usp/ep/jp grade.
Related News: This scheme also stipulates minimum domestic value addition in different target segments. Fermentation based products should have at least 90% and chemical synthesis based products should have at least 70% domestic content to qualify for the benefits. N-Methyl-N-ethyl-N’-(4-(benzo(f)-chinolinyl-(7)-azo)-naphthyl-(1))-ethylendiamin manufacturers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. 1,1,1-trifluoro-methanesulfonic acid 8-fluoro-6-methoxy-quinolin-4-yl ester suppliers In the Phase III VICTORIA study, Verquvo met the primary efficacy objective based on a time-to-event analysis. (3R,5S)-5-(aminomethyl)-1-((S)-2-((4-chlorophenethyl)amino)-3-phenylpropyl)pyrrolidin-3-ol vendor & factory A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge.,As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine.
